Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03222414 · ClinicalTrials.gov registry record · NA

Non-invasive Versus Invasive Blood Pressure Measurement in the Morbidly Obese Parturient With Severe Preeclampsia

A NA study, sponsored by Vanderbilt University Medical Center.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT03222414 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03222414, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

The study will compare agreement of invasive blood pressure measurements with non-invasive blood pressure measurements measured with a conical blood pressure and large standard upper arm rectangular cuff in morbidly obese severely hypertensive (systolic blood pressure \> 160 mmHg) parturients.

Interventions

  • DEVICE Non-invasive BP recording with conical Ultracheck Curve BP cuff
  • DEVICE Non-invasive BP recording with traditional cylindrical BP cuff
  • OTHER Direct invasive arterial pressure

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2015-05-01
Est. Completion 2016-01-18
Phase NA

What the Registry Record Tells You About NCT03222414

The ClinicalTrials.gov registry entry for NCT03222414 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Non-invasive BP recording with conical Ultracheck Curve BP cuff is the first listed.

NCT03222414 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03222414 about?

NCT03222414 is a clinical study titled "Non-invasive Versus Invasive Blood Pressure Measurement in the Morbidly Obese Parturient With Severe Preeclampsia". The study will compare agreement of invasive blood pressure measurements with non-invasive blood pressure measurements measured with a conical blood pressure and large standard upper arm rectangular cuff in morbidly obese severely hypertensive (systolic blood pressure \> 160 mmHg) parturients.

What is the current status of trial NCT03222414?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2015-05-01. Estimated completion is 2016-01-18.

What interventions are being tested in trial NCT03222414?

The interventions under investigation include: Non-invasive BP recording with conical Ultracheck Curve BP cuff (DEVICE), Non-invasive BP recording with traditional cylindrical BP cuff (DEVICE), Direct invasive arterial pressure (OTHER).

Who is sponsoring clinical trial NCT03222414?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.